| ABI | ankle-brachial index |
| ACEIs | angiotensin-converting enzyme inhibitors |
| ARBs | angiotensin receptor blockers |
| ATV | atorvastatin |
| AUC | area under the ROC curve |
| BMCs | bone marrow cells |
| BM-MNCs | bone marrow-derived mononuclear cells |
| CI | confidence interval |
| CLI | critical limb ischaemia |
| CRP | C-reactive protein |
| EPC | endothelial progenitor cells |
| HR | hazard ratio |
| MI | myocardial infarct |
| MSCs | mesenchymal stem cells |
| NO-CLI | “no-option” critical limb ischaemia |
| non-RAS | non-renin-angiotensin system |
| OR | odds ratio |
| PAD | peripheral arterial disease |
| RAS | renin-angiotensin system |
| ROC | receiver operating characteristics |
| SD | standard deviation |
| SEM | standard error |
| TASC | Transatlantic Inter-Society Consensus |
| TcPO2 | transcutaneous oxygen pressure |
| VAS | Visual analogue scale |